Secondary Logo

Journal Logo

Most Popular Articles

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis

Andorn, Anne C.; Haight, Barbara R.; Shinde, Sunita; More

Journal of Clinical Psychopharmacology. 40(3):231-239, May/June 2020.

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review

García, Saínza; Martínez-Cengotitabengoa, Mónica; López-Zurbano, Saioa; More

Journal of Clinical Psychopharmacology. 36(4):355-371, August 2016.

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Marder, Stephen R.; Singer, Carlos; Lindenmayer, Jean-Pierre; More

Journal of Clinical Psychopharmacology. 39(6):620-627, November/December 2019.

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings

Caroff, Stanley N.; Yeomans, Karen; Lenderking, William R.; More

Journal of Clinical Psychopharmacology. 40(3):259-268, May/June 2020.

Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study

Devrimci-Ozguven, Halise; Atmaca, Murad; Baran, Zeynep; More

Journal of Clinical Psychopharmacology. 39(6):604-610, November/December 2019.

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Pérez-Iglesias, Rocio; Mata, Ignacio; Martínez-García, Obdulia; More

Journal of Clinical Psychopharmacology. 32(6):804-808, December 2012.

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Afshar, Hamid; Roohafza, Hamidreza; Mohammad-Beigi, Hamid; More

Journal of Clinical Psychopharmacology. 32(6):797-803, December 2012.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder

Freeman, Marlene P.; Hock, Rebecca S.; Papakostas, George I.; More

Journal of Clinical Psychopharmacology. 40(3):287-292, May/June 2020.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

The Effects of a Gluten-Free Diet on Immune Markers and Kynurenic Acid Pathway Metabolites in Patients With Schizophrenia Positive for Antigliadin Antibodies Immunoglobulin G

Friendshuh, C. Renay; Pocivavsek, Ana; Demyonovich, Haley; More

Journal of Clinical Psychopharmacology. 40(3):317-319, May/June 2020.

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Göhler, Karin; Sokolowska, Marta; Schoedel, Kerri A.; More

Journal of Clinical Psychopharmacology. 39(1):46-56, January/February 2019.

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial)

van der Schans, Jurjen; Hak, Eelko; Postma, Maarten; More

Journal of Clinical Psychopharmacology. 39(6):583-590, November/December 2019.

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Sanches, Rafael Faria; de Lima Osório, Flávia; dos Santos, Rafael G.; More

Journal of Clinical Psychopharmacology. 36(1):77-81, February 2016.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Mazereeuw, Graham; Herrmann, Nathan; Oh, Paul I.; More

Journal of Clinical Psychopharmacology. 36(5):436-444, October 2016.

An Alzheimer Disease Challenge Model: 24-Hour Sleep Deprivation in Healthy Volunteers, Impact on Working Memory, and Reversal Effect of Pharmacological Intervention: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Chan Kwong, Anna; Cassé-Perrot, Catherine; Costes-Salon, Marie-Claude; More

Journal of Clinical Psychopharmacology. 40(3):222-230, May/June 2020.

An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder

Preskorn, Sheldon H.; Baker, Bryan; Kolluri, Sheela; More

Journal of Clinical Psychopharmacology. 28(6):631-637, December 2008.

Medication Adherence in Outpatients With Severe Mental Disorders: Relation Between Self-Reports and Serum Level

Jónsdóttir, Halldóra; Opjordsmoen, Stein; Birkenaes, Astrid B.; More

Journal of Clinical Psychopharmacology. 30(2):169-175, April 2010.

Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy

Biffi, Annalisa; Rea, Federico; Scotti, Lorenza; More

Journal of Clinical Psychopharmacology. 40(2):112-121, March/April 2020.

Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study

Vidal, Sonia; Gex-Fabry, Marianne; Bancila, Victor; More

Journal of Clinical Psychopharmacology. 38(6):590-597, December 2018.

Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia: An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Concentration

Citrome, Leslie; Stauffer, Virginia L.; Chen, Lei; More

Journal of Clinical Psychopharmacology. 29(3):278-283, June 2009.

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

Fu, Dong-Jing; Turkoz, Ibrahim; Simonson, R. Bruce; More

Journal of Clinical Psychopharmacology. 36(4):372-376, August 2016.

Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors

Melhuish Beaupre, Lindsay M.; Tiwari, Arun K.; Gonçalves, Vanessa F.; More

Journal of Clinical Psychopharmacology. 40(2):180-185, March/April 2020.

Show: